Regulatory Scrutiny Valeant has faced ongoing regulatory and legal challenges related to accounting, pricing practices, and deceptive business practices. This creates potential opportunities to offer compliance consulting, internal controls improvements, and price governance solutions to reduce risk and restore trust.

Strategic Acquisitions Historically active in acquisitions (e.g., Bausch + Lomb, AcneFree), Valeant demonstrates a pattern of integrating and monetizing portfolio assets. This suggests opportunities to support post-merger integration, portfolio optimization, and analytics to drive synergies.

Technology Stack Adoption of enterprise tools like Salesforce, SAP, SharePoint, and Microsoft 365 indicates readiness for tech-enabled sales, ERP, and collaboration enhancements. Upsell prospects include CRM automation, data integrity, and BPM process improvements.

Market Positioning Large- to mid-sized player footprint with revenue in the multi-billion range and competition from sizable pharma peers. Target opportunities in commercial analytics, market access strategies, and pricing optimization to improve profitability and competitive differentiation.

Growth History Active past launches such as Addyi and portfolio expansions point to a growth-oriented mindset. Propose solutions for R&D pipeline analytics, regulatory intelligence, and go-to-market acceleration to sustain growth trajectories.